摘要:
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them treat a variety of physiological conditions. The compounds of the invention have the generalized formula ##STR1## wherein each T is a substituent group; x is 0, 1, or 2; the group D represents ##STR2## the group R6 represents a variety of possible substituent groups on the carbon chain between D and G, and the group G represents M, ##STR3## in which M represents --CO.sub.2 H, --CON(R.sup.11).sub.2, or --CO.sub.2 R.sup.12 ; and R.sup.13 represents any of the side chains of the 19 noncyclic naturally occurring amino acids.
摘要:
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula ##STR1## wherein each T is a substituted group; x is 0, 1, or 2; the group D represents ##STR2## the group R6 represents a variety of possible substituent groups on the carbon chain between D and G, and the group G represents M, ##STR3## in which M represents --CO.sub.2 H, --CON(R.sup.11).sub.2, or --CO.sub.2 R.sup.12 ; and R.sup.13 represents any of the side chains of the 19 noncyclic naturally occurring amino acids.
摘要:
Nucleosidyl phosphite-borane compounds of the formula: ##STR1## wherein: Nucleoside is a natural or synthetic nucleoside connected to the phosphorus atom via a hydroxyl oxygen; each X is independently selected from O and BHR.sub.3 R.sub.4 ;R.sub.1 is selected from H, alkyl, aryl, alkyaryl, monovalent metal ions, and ammonium cation; R.sub.2 is selected from OR.sub.1 and N(R.sub.5).sub.2, wherein R.sub.5 is independently selected from H, C.sub.1 -C.sub.10 linear or branched alkyl or aryl; R.sub.3 is selected from H, CN, COOH, carboxyl salts, COOR.sub.6 and CONHR.sub.6, wherein R.sub.6 is selected from H, C.sub.1 -C.sub.10 alkyl, alkylaryl and aryl; R.sub.4 is selected from H and C.sub.1 -C.sub.10 alky; and n is 1 to 2.
摘要翻译:下式的核苷亚磷酸酯 - 硼烷化合物:其中:核苷是通过羟基氧与磷原子连接的天然或合成核苷; 每个X独立地选自O和BHR 3 R 4; R 1选自H,烷基,芳基,烷芳基,一价金属离子和铵阳离子; R2选自OR1和N(R5)2,其中R5独立地选自H,C1-C10直链或支链的烷基或芳基; R3选自H,CN,COOH,羧基盐,COOR6和CONHR6,其中R6选自H,C1-C10烷基,烷基芳基和芳基; R4选自H和C1-C10烷基; n为1〜2。
摘要:
Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics.
摘要:
Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics.
摘要:
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula ##STR1## wherein each T is a substituent group; x is 0, 1, or 2; the group D represents ##STR2## the subscript "e" is 2 or 3; the group R.sup.14 represents a variety of possible substituent groups on the cycloalkyl ring between D and G, and the group G represents M, ##STR3## in which M represents --CO.sub.2 H, --CON(R.sup.11).sub.2, or --CO.sub.2 R.sup.12 ; and R.sup.13 represents any of the side chains of the 19 noncyclic naturally occurring amino acids.
摘要:
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula ##STR1## wherein each T is a substituent group; x is 0, 1, or 2; the group D represents ##STR2## the group R6 represents a variety of possible substituent groups on the carbon chain between D and G, and the group G represents M, ##STR3## in which M represents --CO.sub.2 H, --CON(R.sup.11).sub.2, or --CO.sub.2 R.sup.12 ; and R.sup.13 represents any of the side chains of the 19 noncyclic naturally occurring amino acids.
摘要:
The invention comprises organic phosphorus compounds of the general formula wherein R1 and R2, which may be the same or different represent C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylmercapto, C1-C4 alkylamino, di-C1-C4 alkylamine, cyano-substituted di-C1-C4-alkylamino, phenyl, C1-C4 alkylmercapto-substituted phenoxy, phenylamino, or morpholyl radicals or a further group or R2 and R2 together form an alkylene-dioxy group; R3 and R4, which may be the same or different, represent hydrogen atoms or C1-C4 alkyl, cyano-substituted C1-C4 alkyl, or phenyl radicals or the group represents a morpholyl or piperidyl radical; A represents the residue of carbonic, sulphurous, phenyldithiophosphonic, C1-C4 alkoxy-substituted phenyldithiophosphonic, phthalic, halogen-substituted phthalic, or maleic acid; and X represents an electron pair or a sulphur atom. These compounds may be produced by reacting an appropriate organic compound of trivalent phosphorus containing at least one phosphorus-nitrogen band with an appropriate organic or triorganic anhydride to give a compound in which X is an electron pair and, if desired, reacting said compound with elementary sulphur or a sulphur-yielding agent to give a compound in which X is a sulphur atom. The compounds of the invention exhibit pesticidal activity (see Division A5).ALSO:Pesticidal compositions contain an organophosphorus compound of the general formula wherein R1 and R2, which may be the same or different, represent C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylmercapto, C1-C4 alkylamino, di-C1-C4-alkylamino, cyano-substituted-di-C1-C4 alkylamino, phenyl, C1-C4 alkylmercapto-substituted phenoxy, phenylamino, or morpholyl radicals or a further group or R1 and R2 together form an alkylenedioxy group; R3 and R4, which may be the same or different, represent hydrogen atoms or C1-C4 alkyl, cyano-substituted C1-C4 alkyl, or phenyl radicals or the group represents a morpholyl or piperidyl radical; A represents the residue of carbonic, sulphurous, phenyldithiophosphoric, C1-C4 alkoxy-substituted phenyldithiophosphoric, phthalic, halogen substituted phthalic or maleic acid; and X represents an eletron pair or a sulphur atom, in admixture with a solid or liquid diluent or carrier.
摘要:
Dihydrogen metaphosphate can be synthesized via protonation, and can react with a dehydrating agent to afford tetrametaphosphate anhydride. A monohydrogen tetra-metaphosphate organic ester can be derived from the anhydride. A metal tetrametaphosphate complex can be prepared using a metal salt and a dihydrogen tetrametaphosphate.
摘要:
Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics.